Dietrich A. Stephan, President and CEO at NeuBase Therapeutics, Inc. (NBSE), bought 12,000 shares at $5.00 ($60K) on 2021-04-26, disclosed to the SEC on 2021-04-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.